Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Publication Details

Is it sensible to "deform" dose? 3D experimental validation of dose-warping

Yeo UJ, Taylor ML, Supple JR, Smith RL, Dunn L, Kron T, Franich RD

(2012), Med Phys, 39(8), 5065-72

Evaluating the peak-to-valley dose ratio of synchrotron microbeams using PRESAGE fluorescence

Annabell N, Yagi N, Umetani K, Wong C, Geso M

(2012), J Synchrotron Radiat, 19(Pt 3), 332-9

Finding the optimal statistical model to describe target motion during radiotherapy delivery--a Bayesian approach

Herschtal A, Foroudi F, Greer PB, Eade TN, Hindson BR, Kron T

(2012), Phys Med Biol, 57(9), 2743-55

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langl

(2012), BJU Int, 109 Suppl 1, 22-9

A novel methodology for 3D deformable dosimetry

Yeo UJ, Taylor ML, Dunn L, Kron T, Smith RL, Franich RD

(2012), Med Phys, 39(4), 2203-13

The efficacy of PET staging for small-cell lung cancer: a systematic review and cost analysis in the Australian setting

Ruben JD, Ball DL

(2012), J Thorac Oncol, 7(6), 1015-20

Robust calculation of effective atomic numbers: the Auto-Z(eff) software

Taylor ML, Smith RL, Dossing F, Franich RD

(2012), Med Phys, 39(4), 1769-78

Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder

Hindson BR, Turner SL, Millar JL, Foroudi F, Gogna NK, Skala M, Kneebone A, Christie DR, Lehman M, Wiltshire KL, Tai KH; RANZCR Faculty of Radiation Oncology Genito-Urinary Group (FROGG)

(2012), J Med Imaging Radiat Oncol, 56(1), 18-30

In situ biological dose mapping estimates the radiation burden delivered to 'spared' tissue between synchrotron X-ray microbeam radiotherapy tracks

Rothkamm K, Crosbie JC, Daley F, Bourne S, Barber PR, Vojnovic B, Cann L, Rogers PA

(2012), PLoS One, 7(1), e29853

Factors associated with anxiety and depression in the management of acoustic neuroma patients

Brooker JE, Fletcher JM, Dally MJ, Briggs RJ, Cousins VC, Malham GM, Smee RI, Kennedy RJ, Burney S

(2012), J Clin Neurosci, 19(2), 246-51

Surgical treatment of poorly visualised and complex cerebrovascular lesions using pre-operative angiographic data as angiographic DynaCT datasets for frameless stereotactic navigation

Tee JW, Dally M, Madan A, Hwang P

(2012), Acta Neurochir, 154(7), 1159-67

Stereotactic radiosurgery for treatment of Cushing disease: an Australian experience

Wein L, Dally M, Bach LA

(2012), Intern Med J, 42(10), 1153-6

The GOFURTGO Study: AGITG phase II study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer

Goldstein D, Spry N, Cummins MM, Brown C, van Hazel GA, Carroll S, Selva-Nayagam S, Borg M, Ackland SP, Wratten C, Shapiro J, Porter IW, Hruby G, Horvath L, Bydder S, Underhill C, Harvey J, Gebski VJ; Australasian Gastro-Intestinal Trials Group

(2012), Br J Cancer, 106(1), 61-9

Solvation of gold and rare earths by tributyl phosphate

Gagliardi FM, Cashion JD

(2012), Hyperfine Interact, 207(1-3), 13-17

Outcome and prognostic factors in endometrial stromal tumors: a rare cancer network study

Schick U, Bolukbasi Y, Thariat J, Abdah-Bortnyak R, Kuten A, Igdem S, Caglar H, Ozsaran Z, Lössl K, Schleicher U, Zwahlen D, Villette S, Vees H

(2012), Int J Radiat Oncol Biol Phys, 82(5), e757-63

Risk and response adapted therapy for early stage Hodgkin lymphoma: a prospective multicenter study of the Australasian Leukaemia and Lymphoma Group/Trans-Tasman Radiation Oncology Group

Wirth A, Grigg A, Wolf M, Goldstein D, Johnson C, Davis S, Dutu G, Kypreos P, Smith C, Kneebone A, Herzberg M, Joseph D, Catalano J, Roos D, Stone J, Reynolds J

(2011), Leuk Lymphoma, 52(5), 786-95

Biodosimetric quantification of short-term synchrotron microbeam versus broad-beam radiation damage to mouse skin using a dermatopathological scoring system

Priyadarshika RC, Crosbie JC, Kumar B, Rogers PA

(2011), Br J Radiol, 84(1005), 833-42

Quantifying the effects of iodine contrast media on standardised uptake values of FDG PET/CT images: an anthropomorphic phantom study

Abdul Razak HR, Nordin AJ, Ackerly T, Van Every B, Martin R, Geso M

(2011), Australas Phys Eng Sci Med, 34(3), 367-74

Clinical accuracy of ExacTrac intracranial frameless stereotactic system

Ackerly T, Lancaster CM, Geso M, Roxby KJ

(2011), Med Phys, 38(9), 5040-8

DNA damage and repair kinetics after microbeam radiation therapy emulation in living cells using monoenergetic synchrotron X-ray microbeams

Sprung CN, Cholewa M, Usami N, Kobayashi K, Crosbie JC

(2011), J Synchrotron Radiat, 18 (Pt 4), 630-6